nifekalant hydrochloride has been researched along with Ventricular Dysfunction, Left in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, H; Chen, Q; Cheng, X; Fan, S; Hong, K; Hu, J; Huang, L; Huang, Q; Ju, Z; Li, J; Marian, AJ; Wu, Y; Xia, Z; Xiong, Q; You, C; Yu, J; Yuan, P; Zhu, B | 1 |
| Hotoda, K; Kokaji, K; Kumamaru, H; Okamoto, M | 1 |
2 other study(ies) available for nifekalant hydrochloride and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Efficacy of Nifekalant in Patients With Wolff-Parkinson-White Syndrome and Atrial Fibrillation: Electrophysiological and Clinical Findings.
Topics: Accessory Atrioventricular Bundle; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Pyrimidinones; Tachycardia, Supraventricular; Ventricular Dysfunction, Left; Wolff-Parkinson-White Syndrome | 2019 |
Experience with nifekalant hydrochloride in a patient with ischemic cardiomyopathy and severe ventricular dysfunction after dor operation.
Topics: Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Cardiomyopathies; Electric Countershock; Humans; Male; Middle Aged; Myocardial Ischemia; Pyrimidinones; Tachycardia, Ventricular; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |